Professor, Biochemistry and Biophysics, UCSF
CEO and Managing Partner, Detroit Venture Partners
Co-Founder and Executive Chairman, Smartsheet.com
President and COO, Tasktop Technologies
Managing Director, MIT Entrepreneurship Center
President, University of Texas MD Anderson Cancer Center
Founder and CTO, Shopximity
President and CEO, Complete Genomics
|
|
| Entry | Author | Date | Location | |
|---|---|---|---|---|
| Sarepta Holds Its Breath as Feds Order Halt to Ebola Work | Luke Timmerman | 08/07/12 | Seattle | |
| Pathogenetix Nabs $4M | Erin Kutz | 08/01/11 | Boston | |
| Debt, Equity Deals for Pathogenetix | Erin Kutz | 11/05/10 | Boston | |
| AVI Nabs $11.5M Defense Contract | Luke Timmerman | 10/05/09 | Seattle | |
| Ebola Fighter AVI Biopharma Gears Up for Biodefense Contracts | Luke Timmerman | 04/29/09 | Seattle | |
| Torrey Pines Therapeutics Licenses Three Drugs to Cenomed | Luke Timmerman | 10/08/08 | San Diego | |
| U.S. Genomics Gets $4.5M, Enters Partnership | Gregory T. Huang | 09/23/08 | Boston | |
| Alnylam’s Ebola Work Gets $7.5 Million Commitment | Luke Timmerman | 08/06/08 | Boston | |
| Page 1 of 1 | ||||